Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;16(3):170-173.
doi: 10.59096/osir.v16i3.264236.

Results and Policy Implications of a COVID-19 Vaccine Post-introduction Evaluation in Thailand, May 2022

Chawetsan Namwat  1 , Prabda Praphasiri  2   3 , Chakrarat Pittayawonganon  4 , Kriengkrai Prasert  3   5 , Sutthichai Nakphook  3   4 , Thanawadee Thantithaveewat  6 , Aree Moungsookjareoun  7 , Monica Fleming  8 , Margaret Hercules  8 , Ann C Moen  8 , Anthony Mounts  9 , Patranuch Sapchookul  2 , Darunee Ditsungnoen  2 , James D Heffelfinger  2   8 , William W Davis  2   8 , Sopon Iamsirithaworn  6
Affiliations

Results and Policy Implications of a COVID-19 Vaccine Post-introduction Evaluation in Thailand, May 2022

Chawetsan Namwat et al. Outbreak Surveill Investig Response OSIR J. 2023 Jul.

Abstract

Thailand initiated a COVID-19 vaccine campaign in February 2021, and by March 2022, approximately 72% of residents over 5 years of age had received two doses of vaccine. We evaluated Thailand's COVID-19 vaccine campaign in Bangkok and in four additional provinces using the World Health Organization COVID-19 post-immunization evaluation (cPIE) protocol. Strengths of the vaccine program included close coordination between different levels and sectors of the Royal Thai Government, close community engagement, and use of national data systems. Areas of the campaign that needed interventions included reviewing cold chain practices, standardizing data forms and addressing bottlenecks in data systems.

Keywords: SARS CoV-2; Thailand; cPIE; campaign; evaluation; vaccination.

PubMed Disclaimer

References

    1. Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021. Jul;5(7):947–53. doi:10.1038/s41562-021-01122-8. - DOI - PubMed
    1. World Health Organization. COVID-19 vaccine post introduction evaluation (cPIE): interim guidance. Geneva: World Health Organization; 2021. Aug 25 [cited 2023 Jul 15]. 17 p. <https://www.who.int/publications/i/item/WHO-2019-nCoV-cPIE-2021.1>
    1. Siddiqui A, Adnan A, Abbas M, Taseen S, Ochani S, Essar MY. Revival of the heterologous prime-boost technique in COVID-19: An outlook from the history of outbreaks. Health Sci Rep. 2022. Feb 23;5(2):e531. doi:10.1002/hsr2.531. - DOI - PMC - PubMed
    1. Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, Patcharanarumol W, Mills A. Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet. 2018. Mar 24;391(10126):1205–23. doi:10.1016/S0140-6736(18)30198-3. - DOI - PubMed
    1. Rajatanavin N, Tuangratananon T, Suphanchaimat R, Tangcharoensathien V. Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Glob Health. 2021. Jul;6(7):e006178. doi:10.1136/bmjgh-2021-006178. - DOI - PMC - PubMed

LinkOut - more resources